It is very uncertain whether ultrasound‐accelerated thrombolysis changes amputation rate compared with thrombolysis alone (very low certainty).
It is very uncertain whether ultrasound‐accelerated thrombolysis changes major bleeding compared with thrombolysis alone (very low certainty).
It is very uncertain whether ultrasound‐accelerated thrombolysis changes clinical success ‐ increase in ABI by at least 0.2 compared with thrombolysis alone (very low certainty).
It is very uncertain whether ultrasound‐accelerated thrombolysis changes adverse events compared with thrombolysis alone (very low certainty).
The review found no eligible studies for this question.
Standard testing plus PET/CT scanning showed no clear difference in cancer‐related mortality3 compared with standard testing alone (moderate certainty).
The review found no eligible studies for this question.
Standard testing plus PET/CT scanning showed no clear difference in VTE‐related morbidity5 compared with standard testing alone (moderate certainty).
Standard testing plus PET/CT scanning showed no clear difference in stage of cancer ‐ early compared with standard testing alone (low certainty).
Standard testing plus PET/CT scanning showed no clear difference in stage of cancer ‐ advanced compared with standard testing alone (low certainty).
Standard testing plus PET/CT scanning showed no clear difference in frequency of an underlying cancer diagnosis8 compared with standard testing alone (moderate certainty).
Standard testing plus PET/CT scanning showed no clear difference in all‐cause mortality1 compared with standard testing alone (moderate certainty).
The LNG‐IUS with endometrial surveillance probably leads to lower endometrial polyps compared with endometrial surveillance alone (moderate certainty).
The LNG‐IUS with endometrial surveillance probably leads to lower endometrial hyperplasia compared with endometrial surveillance alone (moderate certainty).
The LNG‐IUS with endometrial surveillance showed no clear difference in fibroids compared with endometrial surveillance alone (moderate certainty).
The LNG‐IUS with endometrial surveillance probably leads to higher abnormal vaginal bleeding or spotting compared with endometrial surveillance alone (moderate certainty).